Secondary central nervous system lymphoma: risk factors and prophylaxis.


Patients diagnosed with diffuse large-cell lymphoma, peripheral T-cell non-Hodgkin's lymphoma or mantle cell lymphoma (either with a high serum lactate dehydrogenase level), more than one extranodal site, or who are a high risk according to the international Prognostic Index, should receive central nervous system prophylaxis either with intrathecal or high… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.